Skip to Content
  • Company
    United Therapeutics
  • Title
    Chairman and CEO

Rothblatt always seems to think big. After all, she launched United Therapeutics to find a cure for pulmonary arterial hypertension, which restricts blood flow from the heart to the lungs. Rothblatt’s daughter suffered from the life-threatening disease. This year, she teamed up with Synthetic Genomics to develop genetically modified organs in pigs for the purpose of human transplants. She was also the highest paid female and transgender (she was born Martin Rothblott) CEO in America, cashing in over $38 million last year. What may stand out the most was a revelation from a profile in New York Magazine that she is developing a robot that will contain the memories and personality of her wife, Bina. Big thinking may be an understatement. —R.D.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access